Etidocaine

DB08987ApprovedSmall molecule

Etidocaine is marketed under the name Duranest. It is an injectable local anesthetic during surgery, labor, and delivery. Etidocaine has a long duration of activity, but has the main disadvantage...

Mechanism: Pharmacologically active on Voltage-gated sodium channel alpha subunit
Curator reviewed
Formula / weight: C₁₇H₂₈N₂O · 276.417 g/mol (avg)

Resolves to

Compound

UNIII6CQM0F31VCAS36637-18-0ChEMBLCHEMBL492ChEBI4904PubChem37497KEGGD04095

Clinical / RWD

RxNorm4171ATCN01BB07ATCN01BB57

Structure

InChIKeyVTUSIVBDOCDNHS-UHFFFAOYSA-NSMILESCCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1,073Drug interactionsStructured to mechanism, not free text

2ATC codesIncluding every combination product, plus 13 drug categories

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Etidocaine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account